Related Experiment Video

Updated: May 19, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

Development of Chlamydial Type III Secretion System Inhibitors for Suppression of Acute and Chronic Forms of

N A Zigangirova1, E S Zayakin, L N Kapotina

  • 1Gamaleya Research Institute of Epidemiology and Microbiology.

Acta Naturae
|August 11, 2012
PubMed

Insights

Researchers developed novel Type III secretion system (T3SS) inhibitors effective against bacterial infections. These compounds show high efficacy with minimal host cell damage, offering a promising new strategy for antimicrobial drug development.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Pathogenesis

Background:

  • The Type III secretion system (T3SS) is a critical virulence factor in Gram-negative bacteria, essential for both acute and chronic infections.
  • Targeting T3SS offers a promising strategy for developing broad-spectrum antimicrobials with reduced resistance potential.

Purpose of the Study:

  • To identify and develop novel inhibitors of the chlamydial T3SS.
  • To find compounds effective against acute and chronic infections with minimal host toxicity.

Main Methods:

  • Pilot screening using specific cellular and bacterial assays.
  • Chemical optimization and detailed biological activity characterization.
  • Evaluation of inhibitory activity and host cell effects.

Main Results:

  • A new class of chlamydial T3SS inhibitors was discovered.
  • Selected compounds demonstrated high inhibitory activity against T3SS.
  • These inhibitors exhibited minimal damaging effects on eukaryotic cells compared to existing options.

Conclusions:

  • The identified T3SS inhibitors represent a promising advancement in antimicrobial drug development.
  • These compounds offer a potential therapeutic strategy for various bacterial infections.
  • Further preclinical trials are underway to validate their efficacy and safety.
Keywords:
Chlamydiacitotoxicityelectron microscopyinhibitorsmicroscopymorphologythiadiazinesthiohydrazidesthiohydrazonestype III secretion system

More Related Videos

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens07:40

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens

Published on: October 25, 2019

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...